A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)

Stopped early · Phase 2

Conditions studied: Kidney Transplantation

In brief

The purpose of this study is to evaluate if TCD601 can induce allogeneic tolerance in living donor renal transplant recipients

Key facts

Study ID

NCT04803058

Run by

ITB-Med LLC

People needed

7

Starts

2022-12-14

Expected to finish

2026-02-17

Last updated by the study team

2026-07-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Samsung Medical University — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.